Which drug is classified as a prostate anti-inflammatory?

Finasteride is classified as a prostate anti-inflammatory because it is specifically designed to treat conditions related to prostate health, particularly benign prostatic hyperplasia (BPH). Finasteride works by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), a hormone that can contribute to prostate enlargement and associated urinary symptoms. By reducing the levels of DHT, finasteride can help decrease the size of the prostate and alleviate inflammation and discomfort associated with BPH.

The other drugs listed do not have a direct impact on prostate inflammation or related conditions. Hydroxychloroquine is primarily used to treat autoimmune diseases like rheumatoid arthritis and lupus. Prochlorperazine is an antipsychotic used mainly for the treatment of severe nausea and psychotic disorders. Mupirocin is a topical antibiotic used to treat skin infections. Therefore, finasteride stands out as the only drug among the options that directly targets prostate health and inflammation.